AnaptysBio Statistics Share Statistics AnaptysBio has 28M
shares outstanding. The number of shares has increased by -2.71%
in one year.
Shares Outstanding 28M Shares Change (YoY) -2.71% Shares Change (QoQ) -4.19% Owned by Institutions (%) 99.99% Shares Floating 25.2M Failed to Deliver (FTD) Shares 61,421 FTD / Avg. Volume 10.51%
Short Selling Information The latest short interest is 9.38M, so 31.93% of the outstanding
shares have been sold short.
Short Interest 9.38M Short % of Shares Out 31.93% Short % of Float 57.62% Short Ratio (days to cover) 18.23
Valuation Ratios The PE ratio is -2.59 and the forward
PE ratio is -4.44.
AnaptysBio's PEG ratio is
0.16.
PE Ratio -2.59 Forward PE -4.44 PS Ratio 4.12 Forward PS 5.1 PB Ratio 5.3 P/FCF Ratio -2.77 PEG Ratio 0.16
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for AnaptysBio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.51,
with a Debt / Equity ratio of 0.23.
Current Ratio 9.51 Quick Ratio 9.51 Debt / Equity 0.23 Debt / EBITDA -0.17 Debt / FCF -0.12 Interest Coverage -2.29
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $671.18K Profits Per Employee $-1.07M Employee Count 136 Asset Turnover 0.19 Inventory Turnover n/a
Taxes Income Tax 3K Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -40.83% in the
last 52 weeks. The beta is -0.19, so AnaptysBio's
price volatility has been lower than the market average.
Beta -0.19 52-Week Price Change -40.83% 50-Day Moving Average 24.13 200-Day Moving Average 20.38 Relative Strength Index (RSI) 30.1 Average Volume (20 Days) 584,514
Income Statement In the last 12 months, AnaptysBio had revenue of 91.28M
and earned -145.23M
in profits. Earnings per share was -5.12.
Revenue 91.28M Gross Profit 91.28M Operating Income -114.95M Net Income -145.23M EBITDA -92.74M EBIT -95.14M Earnings Per Share (EPS) -5.12
Full Income Statement Balance Sheet The company has 123.08M in cash and 16.04M in
debt, giving a net cash position of 107.04M.
Cash & Cash Equivalents 123.08M Total Debt 16.04M Net Cash 107.04M Retained Earnings -759.33M Total Assets 335.25M Working Capital 256.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -135.34M
and capital expenditures -358K, giving a free cash flow of -135.69M.
Operating Cash Flow -135.34M Capital Expenditures -358K Free Cash Flow -135.69M FCF Per Share -4.78
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -125.93% and -159.1%.
Gross Margin 100% Operating Margin -125.93% Pretax Margin -159.1% Profit Margin -159.1% EBITDA Margin -101.6% EBIT Margin -125.93% FCF Margin -148.66%
